Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Wasatch Advisors is an investment management company specializing in equity funds. The company manages institutional and individual portfolios. The company was formed in 1975 by Sam Stewart and still follows his philosophy of a bottom-up research method that focuses on long-term growth and finding market inefficiencies. Wasatch Advisors maintains its headquarters at Salt Lake City, Utah.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2016 | Quess Corp | Venture Round | 26.5M |
7/2003 | BlueArc | Series D | 47M |
11/2005 | Nanosys | Series C | 0 |
9/2014 | DataStax | Series E | 106M |
2/2019 | Medallia | Series F | 70M |
6/2006 | BlueArc | Venture Round | 29M |
2/2008 | Ocera Therapeutics | Series C | 0 |
10/2001 | Metro Optix | Series C | 0 |
7/2020 | Frequency Therapeutics | Post-IPO Equity | 42.3M |
11/2006 | Orexigen Therapeutics, Inc. | Series C | 30M |
7/2000 | Metro Optix | Series B | 63M |
3/2007 | Orqis Medical | Series D | 12M |
5/2015 | DocuSign | Series F | 0 |
7/2005 | TherOx | Venture Round | 30M |
10/2005 | Ophthonix | Series C | 17M |
11/2009 | Tethys BioScience | Series D | 25M |
1/2006 | Incipient | Series D | 24M |
2/2008 | Incipient | Series E | 15.6M |
3/2006 | Inteliquent | Series C | 12M |
9/2000 | Verticore Technologies | Series B | 5M |
1/2007 | Standard BioTools | Series E | 0 |
7/2020 | Frequency Therapeutics | Post-IPO Equity | 0 |
2/2019 | Medallia | Series F | 0 |
6/2016 | Quess Corp | Venture Round | 0 |
5/2015 | DocuSign | Series F | 0 |
9/2014 | DataStax | Series E | 0 |
11/2009 | Tethys BioScience | Series D | 0 |
2/2008 | Incipient | Series E | 0 |
2/2008 | Ocera Therapeutics | Series C | 0 |
3/2007 | Orqis Medical | Series D | 0 |
1/2007 | Standard BioTools | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|